Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postprandial glucose and its role in type 2 diabetes.
Diabetes Insights Editorial Board; Davidson J, Gough S, Halimi S, Liebl A, Raskin P, Yan G. Diabetes Insights Editorial Board, et al. Among authors: davidson j. Hormones (Athens). 2006 Jul-Sep;5(3):1 p following 217. Hormones (Athens). 2006. PMID: 16955956 No abstract available.
A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial.
Liebl A, Davidson J, Mersebach H, Dykiel P, Tack CJ, Heise T. Liebl A, et al. Among authors: davidson j. J Diabetes Sci Technol. 2013 Sep 1;7(5):1328-36. doi: 10.1177/193229681300700524. J Diabetes Sci Technol. 2013. PMID: 24124961 Free PMC article. Clinical Trial.
Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19).
Charbonnel B, DeFronzo R, Davidson J, Schmitz O, Birkeland K, Pirags V, Scheen A; PROactive investigators. Charbonnel B, et al. Among authors: davidson j. J Clin Endocrinol Metab. 2010 May;95(5):2163-71. doi: 10.1210/jc.2009-1974. Epub 2010 Mar 17. J Clin Endocrinol Metab. 2010. PMID: 20237169 Free article. Clinical Trial.
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial.
Heise T, Tack CJ, Cuddihy R, Davidson J, Gouet D, Liebl A, Romero E, Mersebach H, Dykiel P, Jorde R. Heise T, et al. Among authors: davidson j. Diabetes Care. 2011 Mar;34(3):669-74. doi: 10.2337/dc10-1905. Epub 2011 Feb 1. Diabetes Care. 2011. PMID: 21285389 Free PMC article. Clinical Trial.
3,563 results